Apr 22, 2016 12:30pm EDT Adaptimmune Presents Corporate and Clinical Updates at Investor and Analyst Day
Apr 22, 2016 7:30am EDT Adaptimmune Appoints Leading Immunotherapy Experts from United States and Europe to Inaugural Scientific Advisory Board
Apr 18, 2016 7:30am EDT Adaptimmune Announces New Vice President of Business Development, Wenyong Wang
Apr 07, 2016 9:03am EDT Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver Cancer
Mar 30, 2016 7:40am EDT U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma
Mar 17, 2016 7:56am EDT Adaptimmune Reports Financial Results for the Six-Month Period ended December 31, 2015
Mar 02, 2016 10:30am EST Adaptimmune to Present at Cowen and Company’s 36th Annual Health Care Conference
Feb 17, 2016 2:08pm EST Adaptimmune to Present at the RBC Capital Markets Global Healthcare Conference
